Mandelboim, Michal, et al. “Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta)”. Archives of Clinical and Biomedical Research, vol. 5, no. 5, Oct. 2021, pp. 794-02, https://fortunejournals.org/ojs/index.php/acbr/article/view/14869.